Connor, Clark & Lunn Investment Management Ltd. Shockwave Medical, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$191.17 - $325.63 $1.1 Million - $1.87 Million	-5,753 Reduced 24.0%	18,214 $5.93 Million
Q4 2023 Feb 09, 2024	SELL	$160.99 - $215.69 $3.18 Million - $4.26 Million	-19,749 Reduced 45.18%	23,967 $4.57 Million
Q3 2023 Nov 13, 2023	SELL	$194.33 - $283.97 $3.05 Million - $4.46 Million	-15,708 Reduced 26.43%	43,716 $8.7 Million
Q2 2023 Aug 10, 2023	BUY	$223.05 - $302.68 $8.4 Million - $11.4 Million	37,677 Added 173.25%	59,424 $17 Million
Q1 2023 May 09, 2023	SELL	$175.41 - $217.92 $1.86 Million - $2.32 Million	-10,628 Reduced 32.83%	21,747 $4.72 Million
Q4 2022 Feb 10, 2023	BUY	$204.38 - $296.82 $6.62 Million - $9.61 Million	32,375 New	32,375 $6.66 Million
Q1 2021 May 13, 2021	SELL	$92.73 - $142.05 $208,827 - $319,896	-2,252 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$67.44 - $103.72 $151,874 - $233,577	2,252 New	2,252 $234,000

Others Institutions Holding SWAV

# of Institutions

Shares Held

321K

Call Options Held

1.9K

Put Options Held

View Full List

About Shockwave Medical, Inc.

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

More about SWAV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account